Tzyh-Chang Hwang, Ph.D., University of Missouri School of Medicine (image) University of Missouri School of Medicine Share Print E-Mail Caption MU scientist Tzyh-Chang Hwang, Ph.D., and colleagues have redefined a key regulatory process in the defective protein responsible for cystic fibrosis, which could change treatment for patients with the lethal genetic disease. Described in the current issue of the Proceedings of the National Academy of Sciences, Hwang's research could reveal a way to improve the effectiveness of the first drug that targets the underlying cause of cystic fibrosis. Credit University of Missouri School of Medicine Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.